Two Sigma Investments
RGEN icon

Two Sigma Investments’s Repligen RGEN Stock Holding History

Two Sigma Investments’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,200
Closed -$2.97M – 4033
2021
Q4 		$2.97M Buy
11,200
+6,800
+155% +$1.83M 0.01% 1581
2021
Q3 		$1.27M Buy
4,400
+300
+7% +$77K ﹤0.01% 2389
2021
Q2 		$818K Buy
4,100
+2,000
+95% +$388K ﹤0.01% 2660
2021
Q1 		$408K Buy
+2,100
New +$431K ﹤0.01% 3104
2020
Q4 		– Sell
-2,300
Closed -$339K – 3685
2020
Q3 		$339K Buy
+2,300
New +$329K ﹤0.01% 2509

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Two Sigma Investments's RGEN Position: Q1 2026 in Review

Two Sigma Investments sold out of Repligen (RGEN) in Q1 2026, closing a stake of 8,400 shares — an estimated $1.38M sold.

Two Sigma Investments first reported a position in RGEN in Q2 2013 and held it in 31 quarters. The position peaked at $64.9M in Q3 2024. 443 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Two Sigma Investments reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 8,400 Repligen shares in Q1 2026, an estimated $1.38M.
  • Two Sigma Investments first reported a position in Repligen in Q2 2013 and held it in 31 quarters.
  • Two Sigma Investments's Repligen position peaked at $64.9M in Q3 2024.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.